When reimplanted in vivo, targeting individual PTIS proteins such as IL-6 could slow PTR tumor growth but broader PTIS inhibition via type I IFN signaling disruption provided a more potent anti-tumor effect. The gene discussed is IL6; the disease is neoplasm.